...
首页> 外文期刊>Kidney Research and Clinical Practice >Clinical outcome of percutaneous thrombectomy of dialysis access thrombosis by an interventional nephrologist
【24h】

Clinical outcome of percutaneous thrombectomy of dialysis access thrombosis by an interventional nephrologist

机译:介入性肾脏病专家经皮血栓切除术透析通路血栓形成的临床结果

获取原文
           

摘要

Background: Traditionally, the treatment of a thrombosed dialysis access in hemodialysis patients in Korea has been primarily performed by vascular surgeons and interventional radiologists. The objective of this study was to evaluate the outcome of percutaneous thrombectomy procedures performed by an interventional nephrologist. Methods: From October 2010 to May 2014, 75 consecutive percutaneous thrombectomies were performed on 42 patients treated with maintenance hemodialysis. All percutaneous thrombectomy procedures were performed by an interventional nephrologist in a single hospital in Jeju, Korea. The thrombosed arteriovenous graft and arteriovenous fistula were declotted by thromboaspiration mechanical thrombectomy or pharmacomechanical thrombolysis. Kaplan-Meier survival analysis was performed to analyze the primary and secondary patency after the initial successful thrombectomy. Success and complication rates were identified and compared with the recommendations of the Kidney Disease Dialysis Outcomes Quality Initiative (KDOQI) guideline. Results: The overall clinical success rate was 89.3% (67/75). In the successful cases, the postintervention primary (unassisted) patency rates at 30 days, 90 days, and 180 days were 79.9%, 56.6%, and 25.6%, respectively. The secondary patency rates at 30 days, 90 days, and 180 days were 92.2%, 85.7%, and 83.7%, respectively. There were no major complications, and all complications were treated successfully during the procedure. Conclusion: The clinical success rate and primary patency rate at 3 months exceeded the recommendations of the KDOQI guideline, and were comparable to that of other reports. Percutaneous thrombectomy by an interventional nephrologist was safe and effective.
机译:背景:传统上,韩国血液透析患者的血栓性透析途径的治疗主要是由血管外科医师和介入放射科医生进行的。这项研究的目的是评估由介入性肾脏科医生进行的经皮血栓切除术的结果。方法:2010年10月至2014年5月,对42例维持性血液透析患者进行了75次连续的经皮血栓切除术。所有经皮血栓切除术程序都是由介入性肾脏科医生在韩国济州的一家医院进行的。通过血栓抽吸机械血栓切除术或药物机械溶栓术对血栓形成的动静脉移植物和动静脉瘘置塞。最初成功完成血栓切除术后,进行Kaplan-Meier生存分析以分析主要和次要通畅性。确定成功率和并发症发生率,并将其与《肾脏病透析结果质量倡议》(KDOQI)指南的建议进行比较。结果:总体临床成功率为89.3%(67/75)。在成功的病例中,干预后30天,90天和180天的原发(无辅助)通畅率分别为79.9%,56.6%和25.6%。 30天,90天和180天时的二次通畅率分别为92.2%,85.7%和83.7%。没有重大并发症,并且在手术过程中所有并发症均得到成功治疗。结论:3个月时的临床成功率和原发通畅率超过了KDOQI指南的建议,与其他报告相当。介入性肾病专家经皮血栓切除术是安全有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号